FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100159536> ?p ?o ?g. }

• W2100159536 endingPage "493" @default.
• W2100159536 startingPage "479" @default.
• W2100159536 abstract "After the launch of dipeptidyl peptidase-4 (DPP-4), a new oral hypoglycemic drug (OHD), in December 2009, severe hypoglycemia cases were reported in Japan. Although the definite cause was unknown, co-administration with sulfonylureas (SU) was suspected as one of the potential risk factors. The Japan Association for Diabetes Education and Care (JADEC) released a recommendation in April 2010 to lower the dose of three major SUs (glimepiride, glibenclamide, and gliclazide) when adding a DPP-4 inhibitor. To evaluate the effectiveness of this risk minimization action along with labeling changes, dispensing records for 114,263 patients prescribed OHDs between December 2008 and December 2010 were identified in the Nihon-Chouzai pharmacy claims database. The adherence to the recommended dosing of SU co-prescribed with DPP-4 inhibitors increased from 46.3% before to 63.8% after the JADEC recommendation (p < 0.01 by time-series analysis), while no change was found in those for SU monotherapy and SU with other OHD co-prescriptions. The adherence was significantly worse for those receiving a glibenclamide prescription. The JADEC recommendation, along with labeling changes, appeared to have a favorable effect on the risk minimization action in Japan. In these instances, a pharmacy claims database can be a useful tool to evaluate risk minimization actions." @default.
• W2100159536 created "2016-06-24" @default.
• W2100159536 creator A5004599472 @default.
• W2100159536 creator A5013992714 @default.
• W2100159536 creator A5023347840 @default.
• W2100159536 creator A5047020724 @default.
• W2100159536 creator A5070608779 @default.
• W2100159536 creator A5075681252 @default.
• W2100159536 date "2012-09-19" @default.
• W2100159536 modified "2023-09-27" @default.
• W2100159536 title "Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan" @default.
• W2100159536 cites W1968736342 @default.
• W2100159536 cites W1969092028 @default.
• W2100159536 cites W1973841652 @default.
• W2100159536 cites W1980915464 @default.
• W2100159536 cites W1983216490 @default.
• W2100159536 cites W2005379446 @default.
• W2100159536 cites W2009392873 @default.
• W2100159536 cites W2014346836 @default.
• W2100159536 cites W2018134000 @default.
• W2100159536 cites W2035979661 @default.
• W2100159536 cites W2043326088 @default.
• W2100159536 cites W2054599204 @default.
• W2100159536 cites W2068605328 @default.
• W2100159536 cites W2083808413 @default.
• W2100159536 cites W2091972898 @default.
• W2100159536 cites W2092918268 @default.
• W2100159536 cites W2092920113 @default.
• W2100159536 cites W2110132657 @default.
• W2100159536 cites W2120718750 @default.
• W2100159536 cites W2133236380 @default.
• W2100159536 cites W2137735081 @default.
• W2100159536 cites W2146901298 @default.
• W2100159536 cites W2158815828 @default.
• W2100159536 cites W2159205789 @default.
• W2100159536 cites W2164160382 @default.
• W2100159536 cites W2320359741 @default.
• W2100159536 doi "https://doi.org/10.3390/pharmaceutics4030479" @default.
• W2100159536 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3834918" @default.
• W2100159536 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24300302" @default.
• W2100159536 hasPublicationYear "2012" @default.
• W2100159536 type Work @default.
• W2100159536 sameAs 2100159536 @default.
• W2100159536 citedByCount "10" @default.
• W2100159536 countsByYear W21001595362013 @default.
• W2100159536 countsByYear W21001595362014 @default.
• W2100159536 countsByYear W21001595362015 @default.
• W2100159536 countsByYear W21001595362017 @default.
• W2100159536 countsByYear W21001595362019 @default.
• W2100159536 countsByYear W21001595362022 @default.
• W2100159536 crossrefType "journal-article" @default.
• W2100159536 hasAuthorship W2100159536A5004599472 @default.
• W2100159536 hasAuthorship W2100159536A5013992714 @default.
• W2100159536 hasAuthorship W2100159536A5023347840 @default.
• W2100159536 hasAuthorship W2100159536A5047020724 @default.
• W2100159536 hasAuthorship W2100159536A5070608779 @default.
• W2100159536 hasAuthorship W2100159536A5075681252 @default.
• W2100159536 hasBestOaLocation W21001595361 @default.
• W2100159536 hasConcept C104863432 @default.
• W2100159536 hasConcept C126322002 @default.
• W2100159536 hasConcept C134018914 @default.
• W2100159536 hasConcept C2426938 @default.
• W2100159536 hasConcept C2776307423 @default.
• W2100159536 hasConcept C2777288759 @default.
• W2100159536 hasConcept C2777448766 @default.
• W2100159536 hasConcept C2778854520 @default.
• W2100159536 hasConcept C2779768347 @default.
• W2100159536 hasConcept C2780035454 @default.
• W2100159536 hasConcept C2780323712 @default.
• W2100159536 hasConcept C2780668416 @default.
• W2100159536 hasConcept C512399662 @default.
• W2100159536 hasConcept C555293320 @default.
• W2100159536 hasConcept C71924100 @default.
• W2100159536 hasConcept C98274493 @default.
• W2100159536 hasConceptScore W2100159536C104863432 @default.
• W2100159536 hasConceptScore W2100159536C126322002 @default.
• W2100159536 hasConceptScore W2100159536C134018914 @default.
• W2100159536 hasConceptScore W2100159536C2426938 @default.
• W2100159536 hasConceptScore W2100159536C2776307423 @default.
• W2100159536 hasConceptScore W2100159536C2777288759 @default.
• W2100159536 hasConceptScore W2100159536C2777448766 @default.
• W2100159536 hasConceptScore W2100159536C2778854520 @default.
• W2100159536 hasConceptScore W2100159536C2779768347 @default.
• W2100159536 hasConceptScore W2100159536C2780035454 @default.
• W2100159536 hasConceptScore W2100159536C2780323712 @default.
• W2100159536 hasConceptScore W2100159536C2780668416 @default.
• W2100159536 hasConceptScore W2100159536C512399662 @default.
• W2100159536 hasConceptScore W2100159536C555293320 @default.
• W2100159536 hasConceptScore W2100159536C71924100 @default.
• W2100159536 hasConceptScore W2100159536C98274493 @default.
• W2100159536 hasIssue "3" @default.
• W2100159536 hasLocation W21001595361 @default.
• W2100159536 hasLocation W21001595362 @default.
• W2100159536 hasLocation W21001595363 @default.
• W2100159536 hasLocation W21001595364 @default.
• W2100159536 hasLocation W21001595365 @default.
• W2100159536 hasOpenAccess W2100159536 @default.
• W2100159536 hasPrimaryLocation W21001595361 @default.

• next